Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 42

    1.

    Novel cell lines derived by long-term culture of primary uveal melanomas.

    Nareyeck G, Zeschnigk M, Bornfeld N, Anastassiou G.

    Ophthalmologica. 2009;223(3):196-201. Epub 2009 Feb 12.PMID: 19212147 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife--first experience on 46 cases]

    Schilling H, Bornfeld N, Talies S, Anastassiou G, Schüler A, Horstmann GA, Jurklies B.

    Klin Monbl Augenheilkd. 2006 Jun;223(6):513-20. German. PMID: 16804822 [PubMed - indexed for MEDLINE]Related articles

    3.

    Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.

    Nareyeck G, Zeschnigk M, Prescher G, Lohmann DR, Anastassiou G.

    Exp Eye Res. 2006 Oct;83(4):858-64. Epub 2006 Jun 5. Review.PMID: 16750193 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Analysis of ocular surface alterations following proton beam radiation in eyes with conjunctival malignant melanoma]

    Westekemper H, Anastassiou G, Sauerwein W, Chauvel P, Bornfeld N, Steuhl KP, Meller D.

    Ophthalmologe. 2006 Jul;103(7):588-95. German. PMID: 16721565 [PubMed - indexed for MEDLINE]Related articles

    5.

    Beta-ray brachytherapy with 106Ru plaques for retinoblastoma.

    Schueler AO, Flühs D, Anastassiou G, Jurklies C, Neuhäuser M, Schilling H, Bornfeld N, Sauerwein W.

    Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1212-21. Epub 2006 May 6.PMID: 16682139 [PubMed - indexed for MEDLINE]Related articles

    6.

    De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.

    Schueler AO, Anastassiou G, Jurklies C, Havers W, Wieland R, Bornfeld N.

    Retina. 2006 Apr;26(4):425-31.PMID: 16603962 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.

    Anastassiou G, Bornfeld N, Schueler AO, Schilling H, Weber S, Fluehs D, Jurklies B, Vij O, Sauerwein W.

    Br J Ophthalmol. 2006 Apr;90(4):447-50.PMID: 16547325 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Beta-ray brachytherapy of retinoblastoma: feasibility of a new small-sized ruthenium-106 plaque.

    Schueler AO, Flühs D, Anastassiou G, Jurklies C, Sauerwein W, Bornfeld N.

    Ophthalmic Res. 2006;38(1):8-12. Epub 2005 Sep 13.PMID: 16166817 [PubMed - indexed for MEDLINE]Related articles

    9.

    Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.

    Wuestemeyer H, Sauerwein W, Meller D, Chauvel P, Schueler A, Steuhl KP, Bornfeld N, Anastassiou G.

    Graefes Arch Clin Exp Ophthalmol. 2006 Apr;244(4):438-46. Epub 2005 Aug 23.PMID: 16133022 [PubMed - indexed for MEDLINE]Related articles

    10.

    Establishment of two cell lines derived from conjunctival melanomas.

    Nareyeck G, Wuestemeyer H, von der Haar D, Anastassiou G.

    Exp Eye Res. 2005 Sep;81(3):361-2. No abstract available. PMID: 15993408 [PubMed - indexed for MEDLINE]Related articles

    11.

    Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.

    Häusler T, Stang A, Anastassiou G, Jöckel KH, Mrzyk S, Horsthemke B, Lohmann DR, Zeschnigk M.

    Int J Cancer. 2005 Oct 10;116(6):909-13.PMID: 15849744 [PubMed - indexed for MEDLINE]Related articles

    12.

    Primary intraocular lymphoma of T-cell type: report of a case and review of the literature.

    Coupland SE, Anastassiou G, Bornfeld N, Hummel M, Stein H.

    Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):189-97. Epub 2004 Dec 10. Review.PMID: 15806372 [PubMed - indexed for MEDLINE]Related articles

    13.

    Differential expression of tissue inhibitor of matrix metalloproteinases 3 in uveal melanoma.

    Nareyeck G, Zeschnigk M, von der Haar D, Schilling H, Bornfeld N, Anastassiou G.

    Ophthalmic Res. 2005 Jan-Feb;37(1):23-8.PMID: 15637418 [PubMed - indexed for MEDLINE]Related articles

    14.

    Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report.

    Coupland SE, Joussen A, Anastassiou G, Stein H.

    Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):482-6. Epub 2004 Dec 7.PMID: 15586289 [PubMed - indexed for MEDLINE]Related articles

    15.

    Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanoma.

    Anastassiou G, Esser M, Bader E, Steuhl KP, Bornfeld N.

    Melanoma Res. 2004 Oct;14(5):381-5.PMID: 15457094 [PubMed - indexed for MEDLINE]Related articles

    16.

    The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators.

    Flühs D, Anastassiou G, Wening J, Sauerwein W, Bornfeld N.

    Med Phys. 2004 Jun;31(6):1481-8.PMID: 15259651 [PubMed - indexed for MEDLINE]Related articles

    17.

    Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.

    Coupland SE, Bechrakis NE, Anastassiou G, Foerster AM, Heiligenhaus A, Pleyer U, Hummel M, Stein H.

    Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):860-70. Epub 2003 Sep 30.PMID: 14605902 [PubMed - indexed for MEDLINE]Related articles

    18.

    Phenotypical characteristics, lifestyle, social class and uveal melanoma.

    Stang A, Ahrens W, Anastassiou G, Jöckel KH.

    Ophthalmic Epidemiol. 2003 Dec;10(5):293-302.PMID: 14566630 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.

    Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, Jöckel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M.

    Cancer Res. 2003 May 15;63(10):2578-84.PMID: 12750282 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Expression of classic and nonclassic HLA class I antigens in uveal melanoma.

    Anastassiou G, Rebmann V, Wagner S, Bornfeld N, Grosse-Wilde H.

    Invest Ophthalmol Vis Sci. 2003 May;44(5):2016-9.PMID: 12714638 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Quality of life in patients with malignant choroidal melanoma after radiotherapy.

    Reimer J, Esser J, Fleiss A, Hessel A, Anastassiou G, Krausz M, Bornfeld N, Franke GH.

    Graefes Arch Clin Exp Ophthalmol. 2003 May;241(5):371-7. Epub 2003 Apr 23.PMID: 12712357 [PubMed - indexed for MEDLINE]Related articles

    22.

    Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma.

    Jurklies B, Anastassiou G, Ortmans S, Schüler A, Schilling H, Schmidt-Erfurth U, Bornfeld N.

    Br J Ophthalmol. 2003 Jan;87(1):84-9.PMID: 12488269 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Occupation as a risk factor for uveal melanoma in Germany.

    Monárrez-Espino J, Stang A, Bromen K, Merzenich H, Anastassiou G, Jöckel KH.

    Scand J Work Environ Health. 2002 Aug;28(4):270-7.PMID: 12199429 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    [Endoscopic resection of malignant melanomas of the uvea after preoperative stereotactic single dose convergence irradiation with the Leksell gamma knife]

    Bornfeld N, Talies S, Anastassiou G, Schilling H, Schüler A, Horstmann GA.

    Ophthalmologe. 2002 May;99(5):338-44. German. PMID: 12043287 [PubMed - indexed for MEDLINE]Related articles

    25.

    [Prognostically relevant markers of malignant melanoma of the uvea]

    Anastassiou G, Tschentscher F, Zeschnigk M.

    Ophthalmologe. 2002 May;99(5):327-32. Review. German. PMID: 12043285 [PubMed - indexed for MEDLINE]Related articles

    26.

    Cadherin expression in uveal melanoma.

    Anastassiou G, Tschentscher F, Zeschnigk M, Bornfeld N.

    Exp Eye Res. 2002 Mar;74(3):423-5. No abstract available. PMID: 12014924 [PubMed - indexed for MEDLINE]Related articles

    27.

    Assessment of genomic instability in breast cancer and uveal melanoma by random amplified polymorphic DNA analysis.

    Papadopoulos S, Benter T, Anastassiou G, Pape M, Gerhard S, Bornfeld N, Ludwig WD, Dörken B.

    Int J Cancer. 2002 May 10;99(2):193-200.PMID: 11979433 [PubMed - indexed for MEDLINE]Related articles

    28.

    Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study.

    Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP.

    Br J Ophthalmol. 2002 Feb;86(2):163-7.PMID: 11815341 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.

    Anastassiou G, Coupland SE, Stang A, Boeloeni R, Schilling H, Bornfeld N.

    J Pathol. 2001 Aug;194(4):466-72.PMID: 11523055 [PubMed - indexed for MEDLINE]Related articles

    30.

    Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma.

    Tschentscher F, Prescher G, Horsman DE, White VA, Rieder H, Anastassiou G, Schilling H, Bornfeld N, Bartz-Schmidt KU, Horsthemke B, Lohmann DR, Zeschnigk M.

    Cancer Res. 2001 Apr 15;61(8):3439-42.PMID: 11309305 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Methodological aspects and problems of a hospital-based case-control study on uveal melanoma. A case study.

    Stang A, Ahrens W, Anastassiou G, Bornfeld N, Jöckel KH.

    Stud Health Technol Inform. 2000;77:111-3. No abstract available. PMID: 11187493 [PubMed - indexed for MEDLINE]Related articles

    32.

    The possible role of radiofrequency radiation in the development of uveal melanoma.

    Stang A, Anastassiou G, Ahrens W, Bromen K, Bornfeld N, Jöckel KH.

    Epidemiology. 2001 Jan;12(1):7-12.PMID: 11138823 [PubMed - indexed for MEDLINE]Related articles

    33.

    Expression of VLA-2, VLA-3, and alpha(v) integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic value.

    Anastassiou G, Schilling H, Djakovic S, Bornfeld N.

    Br J Ophthalmol. 2000 Aug;84(8):899-902.PMID: 10906100 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.

    Coupland SE, Anastassiou G, Stang A, Schilling H, Anagnostopoulos I, Bornfeld N, Stein H.

    J Pathol. 2000 Jun;191(2):120-6.PMID: 10861569 [PubMed - indexed for MEDLINE]Related articles

    35.

    Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: a clinicopathological study.

    Anastassiou G, Schilling H, Stang A, Djakovic S, Heiligenhaus A, Bornfeld N.

    Oncology. 2000;58(1):83-8.PMID: 10644945 [PubMed - indexed for MEDLINE]Related articles

    36.

    T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.

    Coupland SE, Foss HD, Assaf C, Auw-Haedrich C, Anastassiou G, Anagnostopoulos I, Hummel M, Karesh JW, Lee WR, Stein H.

    Ophthalmology. 1999 Nov;106(11):2109-20.PMID: 10571346 [PubMed - indexed for MEDLINE]Related articles

    37.

    The misinterpretation of study results based on statistical significance.

    Stang A, Jöckel KH, Anastassiou G, Bornfeld N.

    Epidemiology. 1999 Jul;10(4):469-70. No abstract available. PMID: 10401890 [PubMed - indexed for MEDLINE]Related articles

    38.

    Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine.

    Meyer N, Duensing S, Anastassiou G, Brevis Nunez F, Grosse J, Ganser A, Atzpodien J.

    Anticancer Res. 1999 Mar-Apr;19(2C):1509-12.PMID: 10365134 [PubMed - indexed for MEDLINE]Related articles

    39.

    Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responses.

    Zorn U, Duensing S, Langkopf F, Anastassiou G, Kirchner H, Hadam M, Knüver-Hopf J, Atzpodien J.

    Cancer Biother Radiopharm. 1997 Jun;12(3):157-65.PMID: 10851462 [PubMed - indexed for MEDLINE]Related articles

    40.

    Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma.

    Anastassiou G, Duensing S, Steinhoff G, Zorn U, Grosse J, Dallmann I, Kirchner H, Ganser A, Atzpodien J.

    Oncology. 1996 Mar-Apr;53(2):127-32.PMID: 8604238 [PubMed - indexed for MEDLINE]Related articles

    41.

    Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line.

    Duensing S, Brevis Nunez F, Meyer N, Anastassiou G, Nasarek A, Grosse J, Buer J, Probst M, Ganser A, Alzpodien J.

    Invasion Metastasis. 1996;16(2):65-72.PMID: 9030241 [PubMed - indexed for MEDLINE]Related articles

    42.

    In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasis.

    Anastassiou G, Duensing S, Steinhoff G, Kirchner H, Ganser A, Atzpodien J.

    Cancer Biother. 1995 Winter;10(4):287-92.PMID: 8590894 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...